Search for: "Precision Dose, Inc. v. USA"
Results 1 - 9
of 9
Sorted by Relevance
|
Sort by Date
7 Dec 2021, 8:33 am
Inc. v. [read post]
1 Apr 2024, 10:58 am
Janssen Pharms., Inc. v. [read post]
12 Oct 2018, 1:24 pm
Delaware of invalidity of claims:Plaintiffs-Appellants Teva Pharmaceuticals USA,Inc., Teva Pharmaceutical Industries, Ltd., Teva Neuroscience,Inc., and Yeda Research and Development Co. [read post]
26 May 2015, 7:42 am
Way back in 2005, the FDA allowed voluntary addition of pharmacogenomic information in drug labeling:The pharmacogenomic data and resulting test or tests may be intended to be included in the drug labeling to choose a dose and dose schedule, to identify patients at risk, or to identify patient responders. [read post]
19 Mar 2022, 2:09 pm
The FDA’s M7 Guidance observes that “[s]tandard risk assessments of known carcinogens assume that cancer risk increases as a function of cumulative dose. [read post]
17 Mar 2020, 1:32 pm
Dose IQ Software Version 9.0.x has been recalled by Baxter Healthcare because of software defects. [read post]
13 Feb 2009, 8:00 am
(Afro-IP) New Zealand Haka war dance now covered by intellectual property (Techdirt) Nigeria Nigerian musicians want payment for music played on airplanes (Afro-IP) Poland PARIS-DAKAR seeks to invalidate world trade mark registration for DAKAR by Polish company by the same name (Class 46) South Africa Delays at the SA registry favour trade mark proprietor: Golden Fried Chicken (Pty) Ltd v Soulsa CC (Afro-IP) Spain Exhaustion of trade… [read post]
10 Sep 2014, 4:30 am
Pfizer, Inc., 2014 U.S. [read post]
22 Mar 2008, 2:00 am
: (Generic Pharmaceuticals & IP),EU: Counterfeit medicines in the EU: a new consultation: (Class 46)Thailand US Trade Representative to ‘talk’ to Thai government: (Generic Pharmaceuticals & IP), US: Cellectis SA files suit against Precision BioSciences, alleging infringement of two patents relating to materials used to make genome modifications in certain types of organisms: (IP Law360), US: PharmaBiotech IP Summit 28-30 May, Philadelphia will address… [read post]